Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Locations

Education & Training

  • PhD, 2008
    Johns Hopkins School of Public Health
  • Fellowship Program, Rheumatology, 2003
    Johns Hopkins Hospital
  • Residency Program, Internal Medicine & Pediatrics, 2000
    Baylor College of Medicine
  • MD, 1996
    Baylor College of Medicine
  • BS, 1992
    Tulane University

Board Certifications

  • American Board of Pediatrics
  • American Board of Internal Medicine

National Provider ID: 1528098258


Biography

Sangeeta Dileep Sule, M.D., Ph.D., started her career as a pediatric rheumatologist by studying cellular and molecular biology at Tulane University. She attended medical school at Baylor College of Medicine and completed a doctorate in philosophy in clinical investigation from Johns Hopkins University School of Public Health. After completing a postdoctoral fellowship in rheumatology at Johns Hopkins University School of Medicine, Dr. Sule taught courses in pediatrics and internal medicine while she practiced in the field.

As the Chief of Rheumatology at Children’s National, Dr. Sule believes in treating the whole child. She continues to support and expand the Division of Rheumatology, while introducing clinics tailored for specific diseases—such as arthritis and lupus. She focuses on providing multidisciplinary resources to pediatric patients diagnosed with rheumatologic disease and is passionate about fusing the latest research into routine practice.

Dr. Sule is also a dedicated mentor, educator and faculty advocate. She served on the medical school admissions committee for Johns Hopkins and on the Office of Women in Science and School of Medicine Advisory Group for many years. She serves on the American College of Rheumatology Pediatric Rheumatology Residents Program Subcommittee.

Heath-Watson S, Sule S. Living with juvenile idiopathic arthritis: Parent and physician perspectives. Rheumatol Ther. 2018.

Sule S, Fontaine K. Metabolic syndrome in adults with a history of juvenile arthritis. Open Access Rheumatol. 2018;(6):67-72.

Sule S, Fontaine K. Abnormal body composition, cardiovascular endurance, and muscle strength in pediatric SLE. Pediatr Rheumatol Online J. 2016;(14):50.

Sule SD, Moodalbail DG, Burnham J, Fivush B, Furth SL. Predictors of arthritis in pediatric patients with lupus. Pediatric rheumatology online journal. 2015;13:30.

Sule S, Moodalbail DG, Burnham J, Fivush B, Furth S. Predictors of kidney disease in a cohort of pediatric patients with lupus. Lupus. 2015;(24):862-868.

Sule S, Fivush B, Neu A, Furth S. Increased hospitalization and death in patients with ESRD secondary to lupus. Lupus. 2012;(21):1208-1213.

Sule S, Fivush B, Neu A, Furth S. Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatric nephrology (Berlin,Germany). 2011;26(1):93-8.

Sule SD, Fadrowski JJ, Fivush BA, Gorman G, Furth SL. Reduced albumin levels and utilization of arteriovenous access in pediatric patients with systemic lupus erythematosus (SLE). Pediatric nephrology (Berlin,Germany). 2007;22(12):2041-2046.

Sule S, Petri M. Socioeconomic status in systemic lupus erythematosus. Lupus. 2006; 15(11):720-3.

Sule SD, Wigley FM. Treatment of scleroderma: an update. Expert opinion on investigational drugs. 2003;12(3):471-482.